Stock Analysis on Net
Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

$24.99

Price to Operating Profit (P/OP)
since 2005

Microsoft Excel

Paying user area

Try for free

Regeneron Pharmaceuticals Inc. pages available for free this week:

The data is hidden behind: . Unhide it.

Get access

This is a one-time payment. There is no automatic renewal.

We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Apple Pay Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Calculation

Regeneron Pharmaceuticals Inc., P/OP, long-term trends, calculation

Microsoft Excel
P/OP = Share price1, 2, 3 ÷ Operating profit per share1 Operating profit per share1 = Income (loss) from operations1
(in thousands)		 ÷ No. shares of common stock outstanding2
Feb 5, 2024 = ÷ = ÷
Feb 6, 2023 = ÷ = ÷
Feb 7, 2022 = ÷ = ÷
Feb 8, 2021 = ÷ = ÷
Feb 7, 2020 = ÷ = ÷
Feb 7, 2019 = ÷ = ÷
Feb 8, 2018 = ÷ = ÷
Feb 9, 2017 = ÷ = ÷
Feb 11, 2016 = ÷ = ÷
Feb 12, 2015 = ÷ = ÷
Feb 13, 2014 = ÷ = ÷
Feb 15, 2013 = ÷ = ÷
Feb 21, 2012 = ÷ = ÷
Feb 17, 2011 = ÷ = ÷
Feb 18, 2010 = ÷ = ÷
Feb 26, 2009 = ÷ = ÷
Feb 27, 2008 = ÷ = ÷
Mar 12, 2007 = ÷ = ÷
Feb 28, 2006 = ÷ = ÷

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).

1 US$

2 Data adjusted for splits and stock dividends.

3 Closing price as at the filing date of Regeneron Pharmaceuticals Inc. Annual Report.

Comparison to Competitors

Regeneron Pharmaceuticals Inc., P/OP, long-term trends, comparison to competitors

Microsoft Excel
Regeneron Pharmaceuticals Inc. AbbVie Inc. Amgen Inc. Danaher Corp. Gilead Sciences Inc. Moderna Inc. Thermo Fisher Scientific Inc.
Feb 5, 2024
Feb 6, 2023
Feb 7, 2022
Feb 8, 2021
Feb 7, 2020
Feb 7, 2019
Feb 8, 2018
Feb 9, 2017
Feb 11, 2016
Feb 12, 2015
Feb 13, 2014
Feb 15, 2013
Feb 21, 2012
Feb 17, 2011
Feb 18, 2010
Feb 26, 2009
Feb 27, 2008
Mar 12, 2007
Feb 28, 2006

Based on: 10-K (reporting date: 2023-12-31), 10-K (reporting date: 2022-12-31), 10-K (reporting date: 2021-12-31), 10-K (reporting date: 2020-12-31), 10-K (reporting date: 2019-12-31), 10-K (reporting date: 2018-12-31), 10-K (reporting date: 2017-12-31), 10-K (reporting date: 2016-12-31), 10-K (reporting date: 2015-12-31), 10-K (reporting date: 2014-12-31), 10-K (reporting date: 2013-12-31), 10-K (reporting date: 2012-12-31), 10-K (reporting date: 2011-12-31), 10-K (reporting date: 2010-12-31), 10-K (reporting date: 2009-12-31), 10-K (reporting date: 2008-12-31), 10-K (reporting date: 2007-12-31), 10-K (reporting date: 2006-12-31), 10-K (reporting date: 2005-12-31).